Part Details | ESOMEPRAZOLE MAGNES
6505-01-598-8159
Alternate Parts: NEXIUM DR CAPSULES, NDC00186502054, NDC00186-5020-54, 26083, 6505NCM116565, NDC00378235077, NDC00378-2350-77, NDC00093645098, NDC00093-6450-98, 6505-01-598-8159, 01-598-8159, 6505015988159, 015988159
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-598-8159
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NEXIUM DR CAPSULES | 36WK2 | ASTRAZENECA PHARMACEUTICALS LP |
| NDC00186-5020-54 | 36WK2 | ASTRAZENECA PHARMACEUTICALS LP |
| 26083 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM116565 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00378-2350-77 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00093-6450-98 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-598-8159
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | ESOMEPRAZOLE MAGNESIUM 20 MG; DELAYED RELEASE CAPSULES; ORAL ADMINISTRATION; FOR TREATMENT OF EROSIVE ESOPHAGITIS AND GERD; BOTTLE OF 90. STORE AT 25 C (77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F). ?SEE USP CONTROLLED ROOM TEMPERATURE|. |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES 20MG 90S |